Overview

Naltrexone in Treatment of Cocaine Dependence - 5

Status:
Completed
Trial end date:
1996-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the efficacy of naltrexone in the treatment of cocaine dependence as measured by: 1) decreased urine benzoylecgonine (BE) levels, 2) decreased cocaine use by self-report, 3) decreased cocaine craving, and 4) retention in treatment.
Phase:
Phase 2
Details
Lead Sponsor:
National Institute on Drug Abuse (NIDA)
Collaborator:
Cincinnati MDRU
Treatments:
Cocaine
Naltrexone